The dynamic interaction between PARPs, immune response, and microtubule stability offers a complex framework for cancer treatment, indicating that approaches aimed at modulating PARP activity could potentially serve to further improve therapeutic efficacies [138, 139]. Here, PARP1 is linked to cancer.